![](/img/cover-not-exists.png)
Organotypic glioma spheroids for screening of experimental therapies: How many spheroids and sections are required?
Philip C. De Witt Hamer, Sieger Leenstra, Cornelis J.F. Van Noorden, Aeilko H. ZwindermanVolume:
75A
Year:
2009
Language:
english
Pages:
7
DOI:
10.1002/cyto.a.20716
File:
PDF, 401 KB
english, 2009